Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to equity ratio is 0.00 as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00.
DEBT TO EQUITY RATIO
0.00
DEBT TO EQUITY RATIO AVG TTM
0.00
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$42.26M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.63M
Debt to Equity Ratio
0.04
TTM Avg
0.10
3Y Avg
0.10
5Y Avg
0.10
Market Cap
$42.83M
Debt to Equity Ratio
0.11
TTM Avg
0.05
3Y Avg
0.04
5Y Avg
0.03
Market Cap
$43.45M
Debt to Equity Ratio
1.32
TTM Avg
0.40
3Y Avg
0.23
5Y Avg
0.32
Market Cap
$44.49M
Debt to Equity Ratio
0.59
TTM Avg
0.44
3Y Avg
0.44
5Y Avg
0.29
Market Cap
$44.71M
Debt to Equity Ratio
7.43
TTM Avg
14.19
3Y Avg
14.19
5Y Avg
14.19
Market Cap
$44.72M
Debt to Equity Ratio
0.00
TTM Avg
0.45
3Y Avg
0.37
5Y Avg
0.27
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $42.26M | 0.00 | 0.00 | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $42.63M | 0.04 | 0.10 | 0.10 | 0.10 |
| Precipio, Inc. (PRPO)vs › | $41.83M | 0.23 | 0.17 | 0.13 | 0.12 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | 0.11 | 0.05 | 0.04 | 0.03 |
| CVRx, Inc. (CVRX)vs › | $42.99M | 2.98 | 1.00 | 0.61 | 0.49 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.45M | 1.32 | 0.40 | 0.23 | 0.32 |
| DarioHealth Corp. (DRIO)vs › | $44.49M | 0.59 | 0.44 | 0.44 | 0.29 |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 7.43 | 14.19 | 14.19 | 14.19 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.00 | 0.45 | 0.37 | 0.27 |
| Veru Inc. (VERU)vs › | $39.64M | 0.09 | 0.30 | 0.38 | 0.35 |
Debt/Equity
0.00
Current Ratio
2.08
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.00 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.00 |
| 2025-03-31 | 0.00 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
